Nanoparticles for tumor-specific intracellular drug delivery

Proceedings of the 31st Annual International Conference of the IEEE Engineering in Medicine and Biology Society: Engineering the Future of Biomedicine, EMBC 2009

Volumn , Issue , 2009, Pages 2403-2405

  Yeo, Yoon ^a   Xu, Peisheng ^a  

^a PURDUE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELLS; CHEMOTHERAPY; CYTOLOGY; SURFACE TREATMENT; TUMORS;

DRUG CARRIER; INTRACELLULAR DRUG DELIVERY; INTRAPERITONEAL; LARGE MARGINS; NANOPARTICLE SYSTEMS; OVARIAN CANCERS;

NANOPARTICLES;

EID: 77950994356     PISSN: None     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1109/IEMBS.2009.5334835     Document Type: Conference Paper

References (23)

1. American-Cancer-Society: "Cancer Facts & Figures 2008", 2008, pp. http://www.cancer.org/downloads/STT/2008CAFFfinalsecured.pd.
2. de Bree, E., Theodoropoulos, P.A., Rosing, H., Michalakis, J., Romanos, J., Beijnen, J.H., and Tsiftsis, D.D.: "Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From laboratory bench to bedside", Cancer Treat. Rev., 2006, 32, (6), pp. 471-482
3. Cannistra, S.A.: "Cancer of the Ovary", N Engl J Med, 2004, 351, (24), pp. 2519-2529
4. Miyagi, Y., Fujiwara, K., Kigawa, J., Itamochi, H., Nagao, S., Aotani, E., Terakawa, N., and Kohno, I.: "Intraperitoneal carboplatin infusion may be a pharmacologically more reasonable route than intravenous administration as a systemic chemotherapy. A comparative pharmacokinetic analysis of platinum using a new mathematical model after intraperitoneal vs. intravenous infusion of carboplatin - A Sankai Gynecology Study Group (SGSG) study", Gynecol. Oncol., 2005, 99, (3), pp. 591
5. Vassileva, V., Grant, J., De Souza, R., Allen, C., and Piquette-Miller, M.: "Novel biocompatible intraperitoneal drug delivery system increases tolerability and therapeutic efficacy of paclitaxel in a human ovarian cancer xenograft model", Cancer Chemother. Pharmacol., 2007, 60, pp. 907-914
6. Trimble, E.L., and Christian, M.C.: "National Cancer Institute - United States strategy regarding intraperitoneal chemotherapy for ovarian cancer", Int. J. Gynecol. Cancer, 2008, 18, pp. 26-28
7. Elferink, F., Vijgh, W.J.F., Klein, I., Bokkel Huinink, W.W., Dubbelman, R., and McVie, J.G.: "Pharmacokinetics of carboplatin after intraperitoneal administration", Cancer Chemother. Pharmacol., 1988, 21, (1), pp. 57
8. Markman, M., Rowinsky, E., Hakes, T., Reichman, B., Jones, W., Lewis, J.L., Jr., Rubin, S., Curtin, J., Barakat, R., and Phillips, M.: "Phase I trial of intraperitoneal taxol: a Gynecoloic Oncology Group study", J. Clin. Oncol., 1992, 10, (9), pp. 1485-1491
9. Armstrong, D.K., Bundy, B., Wenzel, L., Huang, H.Q., Baergen, R., Lele, S., Copeland, L.J., Walker, J.L., and Burger, R.A.: "Intraperitoneal cisplatin and paclitaxel in ovarian cancer", N. Engl. J. Med., 2006, 354, (1), pp. 34-43
10. Ozols, R.F., Bookman, M.A., and Young, R.C.: "Intraperitoneal chemotherapy for ovarian cancer", N. Engl. J. Med., 2006, 354, (15), pp. 1641-1642
11. Vergote, I., Amant, F., Leunen, K., Cadron, I., Van Gorp, T., Neven, P., and Berteloot, P.: "Intraperitoneal chemotherapy in patients with advanced ovarian cancer: The con view", Oncologist, 2008, 13, (4), pp. 410-414
12. Swart, A.M.C., Burdett, S., Ledermann, J., Mook, P., and Parmar, M.K.B.: "Why i.p. therapy cannot yet be considered as a standard of care for the first-line treatment of ovarian cancer: a systematic review", Ann. Oncol., 2008, 19, (4), pp. 688-695
13. Markman, M., and Walker, J.L.: "Intraperitoneal Chemotherapy of Ovarian Cancer: A Review, With a Focus on Practical Aspects of Treatment", J. Clin. Oncol., 2006, 24, (6), pp. 988-994
14. van Vlerken, L.E., Duan, Z., Seiden, M.V., and Amiji, M.M.: "Modulation of Intracellular Ceramide Using Polymeric Nanoparticles to Overcome Multidrug Resistance in Cancer", Cancer. Res., 2007, 67, (10), pp. 4843-4850
15. Xu, P., Gullotti, E., Tong, L., Highley, C.B., Errabelli, D.R., Hasan, T., Cheng, J.-X., Kohane, D.S., and Yeo, Y.: "Intracellular Drug Delivery by Poly(lactic-co-glycolic acid) Nanoparticles, Revisited", Mol. Pharmaceut., 2009, 6, (1), pp. 190-201
16. Chen, H., Kim, S., Li, L., Wang, S., Park, K., and Cheng, J.-X.: "Release of hydrophobic molecules from polymer micelles into cell membranes revealed by Forster resonance energy transfer imaging", Proc. Natl. Acad. Sci. U. S. A., 2008, pp. 6596-6601
17. Chen, H., Kim, S., He, W., Wang, H., Low, P.S., Park, K., and Cheng, J.-X.: "Fast Release of Lipophilic Agents from Circulating PEG-PDLLA Micelles Revealed by in Vivo Forster Resonance Energy Transfer Imaging", Langmuir, 2008, 24, (10), pp. 5213-5217
18. Cheng, J.-X.: "Coherent Anti-Stokes Raman Scattering Microscopy", Appl. Spectrosc., 2007, 91, pp. 197-208
19. Gullotti, E., and Yeo, Y.: "Extracellularly activated nanocarriers: A new paradigm of tumor targeted drug delivery", Mol. Pharmaceut., pp. doi:10.1021/mp900090z
20. Gerweck, L.E., and Seetharaman, K.: "Cellular pH gradient in tumor versus normal tissue: Potential exploitation for the treatment of cancer", Cancer Res., 1996, 56, (6), pp. 1194-1198
21. Egeblad, M., and Werb, Z.: "New functions for the matrix metalloproteinases in cancer progression", Nat. Rev. Cancer, 2002, 2, (3), pp. 161-174
22. Lee, E.S., Na, K., and Bae, Y.H.: "Super pH-sensitive multifunctional polymeric micelle", Nano Lett., 2005, 5, (2), pp. 325-329
23. Lee, E.S., Gao, Z., Kim, D., Park, K., Kwon, I.C., and Bae, Y.H.: "Super pH-sensitive multifunctional polymeric micelle for tumor pH(e) specific TAT exposure and multidrug resistance", J. Control. Release, 2008, 129, (3), pp. 228-236